Cover Image
市場調查報告書

MediPoint:診斷用X光掃描影像設備 - 美國市場的分析與預測

MediPoint: Diagnostic X-ray Imaging - US Analysis and Market Forecasts

出版商 GlobalData 商品編碼 307782
出版日期 內容資訊 英文 157 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:診斷用X光掃描影像設備 - 美國市場的分析與預測 MediPoint: Diagnostic X-ray Imaging - US Analysis and Market Forecasts
出版日期: 2014年07月07日 內容資訊: 英文 157 Pages
簡介

疾病的早期診斷是提高生存率所不可或缺的。診斷用X光影像掃描設備是為了達成成人與幼兒患者早期發現及臨床性評估而廣為利用的技術,是疾病管理的基礎。

本報告提供美國的診斷用X光掃描影像設備市場相關調查分析,提供您產業概要,競爭評估,未滿足需求,開發中產品相關驗證,再加上主要企業簡介,市場預測等相關的系統性資訊。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 診斷用X光掃描影像設備的原理
  • 系統概要
  • 操作概要
  • X光掃描影像設備的應用
  • 診斷用X光掃描影像設備的優點和缺點
  • 市場進入
  • 品牌忠誠
  • 法規流程
  • 目前給付趨勢
  • 治療趨勢
  • M&A,主要的夥伴關係

第4章 未滿足需求分析

  • 概要
  • 產品改良
  • 缺乏標準化
  • 成本控制的需求

第5章 市場機會分析

  • 不久的未來將小型化

第6章 推動市場要素和機會

  • 概要
  • 推動因素
  • 障礙

第7章 競爭評估

  • 概要
  • 檢測器技術的演進
  • 類比的X光掃描診斷系統
  • 數位的X光掃描診斷系統
  • CR vs. DR
  • 主要的產品簡介

第8章 開發平台評估

  • 概要
  • Appropriate Digital X-ray Imaging System(EssentialMed)
  • MODIS X-ray System(Tribogenics)
  • Flat-Panel Source-Based Portable X-ray Device(Radius Diagnostics)
  • Diffraction Enhanced Medical Imaging System(NextRay)
  • X-ray Imaging Device(Massachusetts Institute of Technology)
  • TBView 1000(University of Waterloo)

第9章 現在/未來的主要企業

  • 概要
  • 企業策略趨勢
  • 前幾名企業
  • 企業簡介(概要,投資組合,SWOT分析)
    • Agfa Healthcare
    • 佳能
    • Carestream Health
    • FUJIFILM Holdings
    • GE Healthcare
    • 日立Medical
    • Konica Minolta
    • Mindray Medical International
    • Philips Healthcare
    • Samsung Electronics
    • 島津製作所
    • Siemens Healthcare
    • Swissray International
    • 東芝MedicalSystems
    • 其他的企業

第10章 市場預測

  • 企業的市場佔有率
  • 市場收益

第11章 附錄

圖表

目錄
Product Code: GDME1112CFR

An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic X-ray imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic X-ray imaging market in the US, the 5EU (France, Germany, Italy, Spain, and the UK), and some of the Asia-Pacific (APAC) regions (Australia, China, India, and Japan), and identifies the unmet needs in this diagnostic X-ray systems market. This report also discusses physician attitudes towards the utilization and perception of different types of X-ray imaging techniques, and the future of diagnostic X-ray imaging in the face of rapid technological advancements and other advanced imaging modalities.

The market share of the companies operating within the diagnostic X-ray imaging market in the US in terms of revenue in 2012. While factors such as reimbursement are currently not a challenge in the US for diagnostic X-ray imaging when used in its proper indications, KOLs interviewed for this report indicated that due to lower physician fees for diagnostic X-ray imaging compared with other imaging techniques, such as MRI and CT, physicians have less of a monetary incentive to perform this test compared with the other procedures.

Scope

  • An overview of Diagnostic X-Ray Imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the US Diagnostic X-Ray Imaging market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for Diagnostic X-Ray Imaging.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Diagnostic X-Ray Imaging sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors.

Reasons to buy

  • Understand the trends shaping and driving the US Diagnostic X-Ray Imaging market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the US Diagnostic X-Ray Imaging market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the US Diagnostic X-Ray Imaging market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Principle of Diagnostic X-ray Imaging
  • 3.2. System Overview
  • 3.3. Operation Overview
  • 3.4. Applications of X-ray Imaging
    • 3.4.1. Overview
    • 3.4.2. Chest Radiography
    • 3.4.3. Skeletal Defects and Pathology
    • 3.4.4. Abdominal and Gastrointestinal Examinations
  • 3.5. Advantages and Disadvantages of Diagnostic X-ray Imaging
    • 3.5.1. Overview
    • 3.5.2. SWOT Analysis
  • 3.6. Market Access
    • 3.6.1. Product Life Cycle
    • 3.6.2. Purchasing Decisions
  • 3.7. Brand Loyalty
  • 3.8. Regulatory Process
  • 3.9. Current Reimbursement Trends
  • 3.10. Procedure Trends
    • 3.10.1. Overview
    • 3.10.2. US
  • 3.11. Mergers and Acquisitions, Key Partnerships

4. Unmet Needs Analysis

  • 4.1. Overview
  • 4.2. Product Improvement
  • 4.3. Lack of Standardization
  • 4.4. Need for Cost-Containment

5. Market Opportunity Analysis

  • 5.1. Lighter X-ray Imaging Systems on the Horizon

6. Market Drivers and Barriers

  • 6.1. Overview
  • 6.2. Driver: Rising Prevalence of Diseases and Aging Population
    • 6.2.1. Sports-Related Injuries
    • 6.2.2. Trauma
    • 6.2.3. Smoking
    • 6.2.4. Aging
  • 6.3. Driver: Escalating Population
  • 6.4. Driver: Increased Demand for Cost-Effective Quality Healthcare
  • 6.5. Driver: Implementation of PACS/RIS to Drive Growth in Digital X-ray Imaging
  • 6.6. Driver: Increased Patient Awareness Regarding Excessive Radiation Dose Associated with CT Imaging
  • 6.7. Driver: Digital Tomosynthesis Unlocks New Frontiers for X-ray Imaging
  • 6.8. Driver: Sustained Monitoring Applications Using Diagnostic X-ray Imaging
  • 6.9. Driver: Digital Mobile Radiography Systems
  • 6.10. Driver: Steady Reimbursement and Other Government Funding
  • 6.11. Barrier: Growth of X-ray Examinations is Inhibited by Advanced Imaging Modalities
  • 6.12. Barrier: Shortage of Radiologists
  • 6.13. Barrier: Lack of Enthusiasm Surrounding X-ray Imaging, and Shrinking Radiology Training
  • 6.14. Barrier: Less Monetary Incentive to Use X-ray Imaging Compared with Other Technique
  • 6.15. Barrier: Lifestyle-Related Diseases Negatively Impact the Use of X-ray Imaging
  • 6.16. Barrier: Reduced Hospital Budgets
  • 6.17. Barrier: Refurbished Equipment Sales
  • 6.18. Barrier: Medical Device Excise Tax
  • 6.19. Barrier: Hospital Consolidation

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Evolution of Detector Technology
  • 7.3. Analog X-ray Systems
    • 7.3.1. Overview
    • 7.3.2. SWOT Analysis
  • 7.4. Digital X-ray Systems
    • 7.4.1. Overview
    • 7.4.2. CR X-ray Systems
    • 7.4.3. DR X-ray Systems
  • 7.5. CR Versus DR
  • 7.6. Key Product Profiles
    • 7.6.1. AeroDR X70 (Konica Minolta)
    • 7.6.2. FCR Profect One Plus/CS Plus (Fujifilm Holdings)
    • 7.6.3. ddRFormula (Swissray International)
    • 7.6.4. DigitalDiagnost (Philips Healthcare)
    • 7.6.5. Digix (Allengers Medical Systems)
    • 7.6.6. DirectView (Carestream Health)
    • 7.6.7. Discovery XR656 (GE Healthcare)
    • 7.6.8. DX-D 100(Agfa Healthcare)
    • 7.6.9. Mobilett XP (Siemens Healthcare)
    • 7.6.10. Proteus XR/a (GE Healthcare)
    • 7.6.11. Radrex-i (Toshiba Medical Systems)
    • 7.6.12. Ysio (Siemens Healthcare)

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Appropriate Digital X-ray Imaging System (EssentialMed)
    • 8.2.1. Overview
    • 8.2.2. SWOT Analysis
  • 8.3. MODIS X-ray System (Tribogenics)
    • 8.3.1. Overview
    • 8.3.2. SWOT Analysis
  • 8.4. Flat-Panel Source-Based Portable X-ray Device (Radius Diagnostics)
    • 8.4.1. Overview
    • 8.4.2. SWOT Analysis
  • 8.5. Diffraction Enhanced Medical Imaging System (NextRay)
    • 8.5.1. Overview
    • 8.5.2. SWOT Analysis
  • 8.6. X-ray Imaging Device (Massachusetts Institute of Technology)
    • 8.6.1. Overview
    • 8.6.2. SWOT Analysis
  • 8.7. TBView 1000 (University of Waterloo)
    • 8.7.1. Overview
    • 8.7.2. SWOT Analysis

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Trends in Corporate Strategy
  • 9.3. Who Is on Top?
  • 9.4. Agfa Healthcare
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Canon
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. Carestream Health
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. Fujifilm Holdings
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. GE Healthcare
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Hitachi Medical
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. Konica Minolta
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. Mindray Medical International
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Philips Healthcare
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Samsung Electronics
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Shimadzu Corporation
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. Siemens Healthcare
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Swissray International
    • 9.16.1. Overview
    • 9.16.2. Portfolio Assessment
    • 9.16.3. SWOT Analysis
  • 9.17. Toshiba Medical Systems
    • 9.17.1. Overview
    • 9.17.2. Portfolio Assessment
    • 9.17.3. SWOT Analysis
  • 9.18. Other Companies

10. Market Outlook

  • 10.1. Company Market Share
  • 10.2. Market Revenue

11. Appendix

  • 11.1. Bibliography
  • 11.2. Definitions
  • 11.3. Abbreviations
  • 11.4. Research Methodology
    • 11.4.1. Overview
    • 11.4.2. Coverage
    • 11.4.3. Secondary Research
  • 11.5. Physicians and Specialists Included in this Study
  • 11.6. Primary Research
    • 11.6.1. Primary Research - Key Opinion Leader Interviews
    • 11.6.2. Expert Panel Validation
    • 11.6.3. Stakeholder Survey
  • 11.7. Forecasting Methodology
  • 11.8. About the Authors
    • 11.8.1. Analysts
    • 11.8.2. Global Head of Healthcare
  • 11.9. About GlobalData
  • 11.10. Disclaimer

List of Tables

  • Table 1: Advantages and Disadvantages of X-ray Imaging, 2014
  • Table 2: Diagnostic X-ray Imaging SWOT Analysis, 2014
  • Table 3: Average Product Life Cycle of X-ray Systems
  • Table 4: Recent Key Events in the Diagnostic X-ray Imaging Market
  • Table 5: Product Improvement Strategies
  • Table 6: Equipment Cost-Reduction Strategies
  • Table 7: Diagnostic X-ray Imaging Market - Drivers and Barriers, 2014
  • Table 8: Analog X-ray Systems
  • Table 9: Analog X-ray Systems SWOT Analysis, 2014
  • Table 10: CR X-ray Systems
  • Table 11: CR X-ray Systems SWOT Analysis, 2014
  • Table 12: DR X-ray Systems
  • Table 13: DR X-ray Systems SWOT Analysis, 2014
  • Table 14: Comparison of CR and DR X-ray Technology
  • Table 15: AeroDR X70 Product Profile, 2014
  • Table 16: AeroDR X70 SWOT Analysis, 2014
  • Table 17: FCR Profect One Plus/CS Plus Product Profile, 2014
  • Table 18: FCR Profect One Plus/CS Plus SWOT Analysis, 2014
  • Table 19: ddRFormula Product Profile, 2014
  • Table 20: ddRFormula SWOT Analysis, 2014
  • Table 21: DigitalDiagnost Product Profile, 2014
  • Table 22: DigitalDiagnost SWOT Analysis, 2014
  • Table 23: Digix Product Profile, 2014
  • Table 24: Digix SWOT Analysis, 2014
  • Table 25: DirectView Product Profile, 2014
  • Table 26: DirectView SWOT Analysis, 2014
  • Table 27: Discovery XR656 Product Profile, 2014
  • Table 28: Discovery XR656 SWOT Analysis, 2014
  • Table 29: DX-D 100 Product Profile, 2014
  • Table 30: DX-D 100 SWOT Analysis, 2014
  • Table 31: Mobilett XP Product Profile, 2014
  • Table 32: Mobilett XP SWOT Analysis, 2014
  • Table 33: Proteus XR/a Product Profile
  • Table 34: Proteus XR/a SWOT Analysis, 2013
  • Table 35: Radrex-i Product Profile
  • Table 36: Radrex-i SWOT Analysis, 2014
  • Table 37: Ysio Product Profile, 2014
  • Table 38: Ysio SWOT Analysis, 2014
  • Table 39: Appropriate Digital X-ray Imaging System SWOT Analysis, 2014
  • Table 40: MODIS X-ray System SWOT Analysis, 2014
  • Table 41: Flat-Panel Source-Based Portable X-ray Device SWOT Analysis, 2014
  • Table 42: Diffraction Enhanced Medical Imaging System SWOT Analysis, 2014
  • Table 43: X-ray Imaging Device SWOT Analysis, 2014
  • Table 44: TBView 1000 SWOT Analysis, 2014
  • Table 45: Agfa Healthcare SWOT Analysis, 2014
  • Table 46: Canon SWOT Analysis, 2014
  • Table 47: Carestream Health SWOT Analysis, 2014
  • Table 48: Fujifilm Holdings SWOT Analysis, 2014
  • Table 49: GE Healthcare SWOT Analysis, 2014
  • Table 50: Hitachi Medical SWOT Analysis, 2014
  • Table 51: Konica Minolta SWOT Analysis, 2014
  • Table 52: Mindray Medical International SWOT Analysis, 2014
  • Table 53: Philips Healthcare SWOT Analysis, 2014
  • Table 54: Samsung Electronics SWOT Analysis, 2014
  • Table 55: Shimadzu Corporation SWOT Analysis, 2014
  • Table 56: Siemens Healthcare SWOT Analysis, 2014
  • Table 57: Swissray International SWOT Analysis, 2014
  • Table 58: Toshiba Medical Systems SWOT Analysis, 2014
  • Table 59: Other Companies in the Diagnostic X-ray Imaging Market, 2014
  • Table 60: Diagnostic X-ray Imaging, Company Market Share, US, 2012
  • Table 61: US Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020
  • Table 62: Total Unit Sales of Diagnostic X-ray Systems, US, 2011-2020
  • Table 63: Change in ASP of X-ray Systems, US, 2011-2020
  • Table 64: Primary Research Summary
  • Table 65: Primary Research Participants' Professional Affiliation

List of Figures

  • Figure 1: Electromagnetic Spectrum
  • Figure 2: X-ray Scan of the Ankle
  • Figure 3: Operation of X-ray Imaging
  • Figure 4: Evolution of Detector Technology
  • Figure 5: Types of Digital Detectors
  • Figure 6: Diagnostic X-ray Imaging, Company Market Share, US, 2012
  • Figure 7: US Overall Sales ($m), Diagnostic X-ray Systems, 2011-2020
  • Figure 8: Total Unit Sales of Diagnostic X-ray Systems, US, 2011-2020
  • Figure 9: US Sales Forecast ($m) for Diagnostic X-ray Systems, by Segment, 2013 and 2020
  • Figure 10: Change in ASP of X-ray Systems, US, 2011-2020
  • Figure 11: Primary Research Summary
  • Figure 12: Primary Research Participants' Professional Affiliation
Back to Top